 |
 |
|
|
|
| GATIFLOXACIN |
 |
| 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid 98.5%,powder |
 |
| 112811-59-3 |
 |
| pharmaceutical raw materials |
 |
Product Name:1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
Another Name:GATIFLOXACIN
1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-8-METHOXY-7-(3-METHYLPIPERAZIN-1-YL)-4-OXO-3-QUINOLINECARBOXYLIC ACID
1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDROXY-8-METHOXY-7-(3-METHYL-1-PIPERAZINYL)-4-OXO-3-QUINOLINECARBOXYLIC ACID
1-CYCLOPROPYL-6-FLUORO-8-METHOXY-7-(3-METHYL-PIPERAZIN-1-YL)-4-OXO-1,4-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID
AKOS NCG1-0010
TEQUIN
Gatifloxacin(AM-1155)
CAS:112811-59-3
Molecular Weight:375.39
Molecular Formula:C19H22FN3O4
Assay: 98%
Packing:25kg/drum
Specification: Enterprise Standard
Usage: Gatifloxacin for the treatment of strains caused conjunctivitis and microorganisms mostly Lou strains with antibacterial activity |
|
|
|
|
|
